A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

NCT06266988 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure

Interventions

DRUG: Sacubitril and Valsartan Tablets 97mg/103mg
DRUG: Entresto (Sacubitril and Valsartan Tablets 97mg/103mg)

Sponsor

Viatris Inc.